The role of CDX2 as a tumor suppressor is also supported by the observation that its expression is decreased in human colorectal cancer, and reduced expression of CDX2 is associated with poor overall survival rates in patients with colorectal cancer (18–20). This evidence concerns the gene CDX2 and neoplasm.